Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer

dc.contributor.authorGupta, Swati
dc.contributor.authorMani, Navin
dc.contributor.authorCarvajal, Daniel
dc.contributor.authorBossuyt, Veerle
dc.contributor.authorHo, Kenneth
dc.contributor.authorWeidler, Jodi
dc.contributor.authorWong, Wendy
dc.contributor.authorRhees, Brian
dc.contributor.authorBates, Michael
dc.contributor.authorRimm, David
dc.date.accessioned2022-05-13T14:08:03Z
dc.date.available2022-05-13T14:08:03Z
dc.date.issued2018
dc.description.abstractAn on-demand, closed RT-qPCR, the GeneXpert (GX) system, has the potential to provide biomarker information in low-resourced settings and elsewhere. We used this system with a research use only version of the Breast Cancer STRAT4 cartridge that measures the mRNA expression levels of ERBB2, ESR1, PGR, and MKi67. Here we evaluated the impact of non-macrodissected (non m-d) versus macrodissected (m-d) samples using STRAT4 on formalin-fixed, paraffin-embedded (FFPE) core needle biopsies. Two cohorts were assessed: (1) 60 FFPE infiltrating ductal carcinoma (IDCA) cases and (2) 20 FFPE IDCA cases with ductal carcinoma in situ (DCIS) with a range of HER2 expression as determined by clinical immunohistochemistry and fluorescence in situ hybridization (IHC/FISH). We observed about half of the core needle biopsy area as invasive tumor in both IDCA (mean = 51.5%) and IDCA with DCIS (mean = 53.5%) cohorts, but also found the mRNA levels were independent of tumor area. We found excellent agreement of the mRNA transcript level between the paired samples, m-d versus non m-d, for ERBB2, ESR1, PGR, and MKi67 for both the IDCA and IDCA with DCIS cohorts. No significant difference (P > 0.99) was observed when we compared the mRNA transcript level between the paired samples m-d versus non m-d. In addition, we noted a significant concordance (P < 0.001) between RT-qPCR and IHC/FISH for HER2-positivity, ER-positivity, and PR-positivity, independent of specimen dissection. These data suggest that mRNA expression for ERBB2, ESR, and PGR is sufficiently low in surrounding tissue cells such that macrodissection is not required for assessment of key breast cancer mRNA markers and is independent of the amount of input tumor. This approach may be valuable in settings lacking pathology expertise or using specimen types, such as fine-needle aspirates, where it may be challenging to separate non-tumor from tumor tissue.es
dc.description.versionVersión publicadaes
dc.identifier.urihttps://doi.org/10.1038/s41374-018-0064-1es
dc.identifier.urihttp://hdl.handle.net/11447/6086
dc.language.isoenes
dc.subjectBiomarkers, Tumor / geneticses
dc.subjectBiomarkers, Tumor / metabolismes
dc.subjectBreast Neoplasms / genetics*es
dc.subjectCarcinoma, Intraductal, Noninfiltrating / diagnosises
dc.subjectGene Expression Regulation, Neoplastices
dc.subjectImmunohistochemistry / methods*es
dc.subjectPathology, Clinical / methodses
dc.subjectReceptor, ErbB-2 / genetics*es
dc.subjectReceptors, Estrogen / metabolismes
dc.subjectReceptor, ErbB-2 / metabolismes
dc.titleMacrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast canceres
dc.typeArticlees
dcterms.sourcehttps://doi.org/10.1038/s41374-018-0064-1es

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC FISH in breast cancer.pdf
Size:
1.85 MB
Format:
Adobe Portable Document Format
Description:
Texto completo
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: